Literature DB >> 19869967

THE ROLE OF THE SOLUBLE SPECIFIC SUBSTANCE IN ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPE I.

V Ross1.   

Abstract

1. Feeding the purified soluble specific substance of Type I pneumococcus protects rats against an intraperitoneal injection of the virulent organism. 2. This increased resistance resembles that obtained when the intact (dead) or dissolved bacteria are fed, as follows: (a) one feeding is sufficient, (b) the interval between the feeding and the appearance of the immunity is the same, (c) the duration is approximately the same, (d) when the immunity is exhausted it can be renewed by a new feeding, (e) the immunizing action is type-specific. 3. The differences between the effects of feeding the purified specific substance and the intact or dissolved organism to rats, appear to be quantitative rather than qualitative, the proportion of animals protected and the height of the immunity being generally, though not always, less in the case of the former. 4. In contrast to the immunizing action which the soluble specific substance possesses when administered to rats, feeding it to mice failed to protect them. Neither were mice definitely immunized by parenteral administration. 5. A sodium glycocholate solution of Pneumococcus Type I lost part of its immunizing activity on standing for 1 year. 6. The failure to immunize mice and the loss of activity of the bile salt solution of pneumococcus, on standing, are discussed in terms of (a) the possible presence of a second cell constituent which is active by mouth, and (b) a possible intramolecular change in the type-specific polysaccharide associated with a loss of immunizing action while retaining the precipitin reaction.

Entities:  

Year:  1931        PMID: 19869967      PMCID: PMC2180305          DOI: 10.1084/jem.54.6.899

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : SECOND PAPER.

Authors:  M Heidelberger; O T Avery
Journal:  J Exp Med       Date:  1924-08-31       Impact factor: 14.307

2.  THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : THIRD PAPER.

Authors:  M Heidelberger; W F Goebel; O T Avery
Journal:  J Exp Med       Date:  1925-10-31       Impact factor: 14.307

3.  ORAL IMMUNIZATION AGAINST THE PNEUMOCOCCUS : USE OF BILE SALT DISSOLVED ORGANISMS, ETC., TIME OF APPEARANCE OF IMMUNITY AND DOSAGE.

Authors:  V Ross
Journal:  J Exp Med       Date:  1930-03-31       Impact factor: 14.307

  3 in total
  2 in total

1.  THE FATE OF ORALLY ADMINISTERED SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS TYPES I, II AND III.

Authors:  V Ross
Journal:  J Exp Med       Date:  1932-01-01       Impact factor: 14.307

2.  THE ROLE OF THE SOLUBLE SPECIFIC SUBSTANCE IN ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPES II AND III.

Authors:  V Ross
Journal:  J Exp Med       Date:  1932-01-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.